YSPSAH: Y.S.P. Southeast Asia Holding Berhad - Summary | Jitta

Y.S.P. Southeast Asia Holding Berhad

MAL:YSPSAH

Price
RM2.11
Loss Chance
44.8%
5.15JITTA SCORE
25.94%Over Jitta Line
Jitta Ranking
156 / 1,004
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (53)
Financial Strength (91)
Return to Shareholders (23)
Competitive Advantage (35)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Revenue and EarningEarning decline from 2022-2025
Recent Business PerformanceEarning decline 6.21% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.15
25.94%
5.13
129.18%
3.68
135.70%
Pharmaceuticals
6.10
17.36%
4.54
109.24%
3.28
500.97%
COMPANY DESCRIPTION
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology and health products, as well as traditional herbal medicines, food and health supplements, and over-the-counter products; and offers management services. Y.S.P. Southeast Asia Holding Berhad was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.